Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition

Pranindya Rinastiti; Koji Ikeda; Elda Putri Rahardini; Kazuya Miyagawa; Naoki Tamada; Yuko Kuribayashi; Ken-ichi Hirata; Noriaki Emoto

doi:10.1371/journal.pone.0226049

Loading metrics

Open Access

Peer-reviewed

Research Article

Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition

Pranindya Rinastiti,

Roles Formal analysis, Investigation, Writing – review & editing

Affiliations Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
⨯
Koji Ikeda ,

Roles Conceptualization, Supervision, Writing – original draft

* E-mail: ikedak-circ@umin.ac.jp

Affiliation Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan

http://orcid.org/0000-0002-9972-7255

⨯
Elda Putri Rahardini,

Roles Investigation

Affiliations Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
⨯
Kazuya Miyagawa,

Roles Investigation

Affiliations Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
⨯
Naoki Tamada,

Roles Investigation

Affiliations Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
⨯
Yuko Kuribayashi,

Roles Investigation

Affiliation Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan
⨯
Ken-ichi Hirata,

Roles Supervision

Affiliation Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
⨯
Noriaki Emoto

Roles Funding acquisition, Supervision, Writing – review & editing

Affiliations Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
⨯

Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition

Pranindya Rinastiti,
Koji Ikeda,
Elda Putri Rahardini,
Kazuya Miyagawa,
Naoki Tamada,
Yuko Kuribayashi,
Ken-ichi Hirata,
Noriaki Emoto

Published: February 13, 2020
https://doi.org/10.1371/journal.pone.0226049

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Pulmonary hypertension
Is the Subject Area "Pulmonary hypertension" applicable to this article?

Thanks for your feedback.
Pulmonary arteries
Is the Subject Area "Pulmonary arteries" applicable to this article?

Thanks for your feedback.
Medical hypoxia
Is the Subject Area "Medical hypoxia" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Beta-catenin signaling
Is the Subject Area "Beta-catenin signaling" applicable to this article?

Thanks for your feedback.
Immunoblotting
Is the Subject Area "Immunoblotting" applicable to this article?

Thanks for your feedback.
Pathogenesis
Is the Subject Area "Pathogenesis" applicable to this article?

Thanks for your feedback.